March 6, 2015 — Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system.
The EmpowerCTA+ has initially been launched in the United States then gradually in Europe, and it will be presented at the European Congress of Radiology (ECR), March 4-8 in Vienna, Austria.
The re-engineered device includes advanced touchscreen technology that enables technologists to customize the contrast injection experience right at the patient’s side with new enhancements, including real-time variable flow rates, saline advance and saline jump.
The saline advance function tests a patient’s patency and vein integrity while the saline jump feature minimizes the amount of contrast a patient receives. The injector’s patented extravasation detection accessory (EDA) provides additional safety and peace of mind for the technologist. In addition, its eGFR calculator simplifies calculations for kidney evaluation function prior to contrast delivery. The risk of air embolisms to the patient is reduced due to the system’s built-in tilt sensor and lock.
For more information: www.braccoimaging.com
April 18, 2024 
